A. Patroni

发表

A survey of methicillin-resistant Staphylococcus aureus control strategies in Italy

A. Goglio, A. Pan, L. Signorini, 2013, Infection.

Early Virological Failure after Tenofovir + Didanosine + Efavirenz Combination in HIV-Positive Patients upon Starting Antiretroviral Therapy

A. Antinori, C. Torti, G. Carosi, 2005, Antiviral therapy.

Adherence to Surgical Site Infection Guidelines in Italian Cardiac Surgery Units

F. T. P. Group, C. Santini, G. Carosi, 2009, Infection.

Variable performance of models for predicting methicillin-resistant Staphylococcus aureus carriage in European surgical wards

B. Cooper, S. Harbarth, G. Daikos, 2015, BMC Infectious Diseases.

Vaginal colonization with Candida spp. in human immunodeficiency virus – infected women: a cohort study

A. Matteelli, G. Carosi, A. Patroni, 2006, International journal of STD & AIDS.

A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study.

C. Tinelli, A. Antinori, A. De Luca, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adherence to hand hygiene in an Italian long-term care facility.

G. Carosi, A. Pan, L. Signorini, 2008, American journal of infection control.

Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort.

C. Tinelli, L. Minoli, C. Torti, 2005, The Journal of antimicrobial chemotherapy.

Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy.

S. Di Giambenedetto, C. Torti, N. Manca, 2007, AIDS patient care and STDs.

Lopinavir plasma levels in salvage regimes by a population of highly active antiretroviral therapy-treated HIV-1-positive patients.

A. De Luca, C. Torti, G. Carosi, 2004, AIDS patient care and STDs.

Outcome and Predictive Factors of Mortality in Hospitalized HIV-Patients in Burkina Faso

F. Castelli, G. Carosi, Fiorella Castelli, 2009, Infection.

Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART).

C. Torti, G. Carosi, P. Airó, 2004, Viral immunology.

Why not to use colchicine in COVID-19? An old anti-inflammatory drug for a novel auto-inflammatory disease

L. Andreoli, S. Piantoni, F. Franceschini, 2020, Rheumatology.

HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations.

S. Lo Caputo, F. Mazzotta, L. Scudeller, 2003, The Journal of antimicrobial chemotherapy.

Control and prevention measures for legionellosis in hospitals: A cross‐sectional survey in Italy

M. L. Cristina, B. Casini, C. Pasquarella, 2018, Environmental research.

The human immunodeficiency virus-infected traveler.

F. Castelli, A. Patroni, F. Castelli, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.

R. Bruno, G. Filice, P. Sacchi, 2002, AIDS reviews.

Bcl-2 expression is moderately correlated with long-term variability of CD4 T-cell increase under successful highly active antiretroviral therapy.

C. Tinelli, F. Castelli, C. Torti, 2003, AIDS.

Analysis of HIV‐1 mutation patterns in patients failing antiretroviral therapy

C. Torti, G. Carosi, E. Quiros-Roldan, 2001, Journal of clinical laboratory analysis.

Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy

G. Lippi, G. Bonetti, A. Patroni, 2020, Clinical chemistry and laboratory medicine.

Predictors of Long-Term Immunological Outcome in Rebounding Patients on Protease Inhibitor-Based HAART After Initial Successful Virologic Suppression: Implications for Timing to Switch

C. Tinelli, F. Castelli, C. Torti, 2003, HIV clinical trials.

Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting.

F. Castelli, L. Leone, C. Torti, 2003, Health policy.

Effect of Highly Active Antiretroviral Therapy (HAART) and Hepatitis C Co-Infection on Hyperlipidemia in HIV-Infected Patients: A Retrospective Longitudinal Study

C. Tinelli, F. Castelli, C. Torti, 2002, HIV clinical trials.

Risk factors for previously unknown meticillin-resistant Staphylococcus aureus carriage on admission to 13 surgical wards in Europe.

H. Goossens, B. Cooper, S. Harbarth, 2013, The Journal of hospital infection.

HIV-1 resistance to dideoxynucleoside reverse transcriptase inhibitors: genotypic-phenotypic correlations.

C. Tinelli, S. Lo Caputo, F. Mazzotta, 2004, Journal of acquired immune deficiency syndromes.

Influence of hepatitis C virus coinfection on lipid abnormalities in HIV-positive patients after highly active antiretroviral therapy.

C. Tinelli, F. Castelli, C. Torti, 2002, Journal of acquired immune deficiency syndromes.

Pneumonia in a cardiothoracic intensive care unit: incidence and risk factors.

T. Bordonali, Rosa Mastropierro, A. Manzato, 2009, Journal of cardiothoracic and vascular anesthesia.

Standardized approach to patients with suspected SARS-CoV2 infection at the Emergency Department: the Valcamonica model

Maria Sofia Cotelli, A. Patroni, M. Michelini, 2021, Italian Journal of Emergency Medicine.

Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review

N. Latronico, D. Cattaneo, A. Corona, 2023, Antibiotics.

Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naïve for lopinavir with limited exposure to previous protease inhibitors.

C. Tinelli, A. De Luca, C. Torti, 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retrovirals.

C. Torti, N. Manca, G. Carosi, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Risk factors for previously unknown methicillin-resistant Staphylococcus aureus (MRSA) carriage on admission to 13 surgical wards in Europe

B. Cooper, S. Harbarth, G. Daikos, 2011, BMC Proceedings.

Hand Hygiene and Glove Use Behavior in an Italian Hospital

K. Posfay-Barbe, A. Pan, P. Mondello, 2007, Infection Control & Hospital Epidemiology.

Lipid abnormalities in HIV-infected patients are not correlated with lopinavir plasma concentrations.

A. De Luca, S. Lo Caputo, S. Di Giambenedetto, 2004, Journal of acquired immune deficiency syndromes.

Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients.

Carlo Torti, Valeria Micheli, S. Di Giambenedetto, 2007, International journal of antimicrobial agents.